Personal information

Germany

Activities

Employment (4)

University Hospital Ulm: Ulm, DE

2015 to present | Attending physician (Internal Medicine I)
Employment
Source: Self-asserted source
Thomas J. Ettrich

University Hospital Ulm: Ulm, DE

2012 to 2015 | Consulting physician (Internal Medicine I)
Employment
Source: Self-asserted source
Thomas J. Ettrich

University Hospital in Halle: Halle, DE

2008 to 2012 | Resident physician (Internal Medicine I)
Employment
Source: Self-asserted source
Thomas J. Ettrich

University Hospital Ulm: Ulm, DE

2006 to 2008 | Resident physician (Internal Medicine I)
Employment
Source: Self-asserted source
Thomas J. Ettrich

Professional activities (3)

European Society for Medical Oncology: Lugano, Ticino, CH

Membership
Source: Self-asserted source
Thomas J. Ettrich

Deutsche Krebsgesellschaft eV: Berlin, Berlin, DE

Membership
Source: Self-asserted source
Thomas J. Ettrich

American Society of Clinical Oncology: Alexandria, VA, US

Membership
Source: Self-asserted source
Thomas J. Ettrich

Funding (2)

Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis

2010-07 to 2014-06 | Grant
Martin-Luther-University Halle-Wittenberg (Halle, DE)
Source: Self-asserted source
Thomas J. Ettrich

DocOx (AIO-PK0106): A phase II trial with docetaxel and oxaliplatin as a second-line systemic therapy for patients with advanced and/or metastatic adenocarcinoma of the pancreas—Final results

2015-01 | Award
American Society of Clinical Oncology (VA, VA, US)
GRANT_NUMBER: ASCO Merit Award
Source: Self-asserted source
Thomas J. Ettrich

Works (50 of 56)

Items per page:
Page 1 of 2

Reply to Y. Liang et al

Journal of Clinical Oncology
2025-01-20 | Journal article
Contributors: Lukas Perkhofer; Thomas Seufferlein; Anna Melzer; Thomas J. Ettrich
Source: check_circle
Crossref

Organoid‐based precision medicine in pancreatic cancer

United European Gastroenterology Journal
2024-11-14 | Journal article
Contributors: Alica K. Beutel; Menar Ekizce; Thomas J. Ettrich; Thomas Seufferlein; Jessica Lindenmayer; Johann Gout; Alexander Kleger
Source: check_circle
Crossref

S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1

Zeitschrift für Gastroenterologie
2024-10 | Journal article
Contributors: Thomas Seufferlein; Julia Mayerle; Stefan Boeck; Thomas Brunner; Thomas J. Ettrich; Lars Grenacher; Thomas Mathias Gress; Thilo Hackert; Volker Heinemann; Angelika Kestler et al.
Source: check_circle
Crossref

S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1

Zeitschrift für Gastroenterologie
2024-10 | Journal article
Contributors: Thomas Seufferlein; Julia Mayerle; Stefan Boeck; Thomas Brunner; Thomas J. Ettrich; Lars Grenacher; Thomas Mathias Gress; Thilo Hackert; Volker Heinemann; Angelika Kestler et al.
Source: check_circle
Crossref

Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)

Journal of Clinical Oncology
2024-09-10 | Journal article
Contributors: Thomas J. Ettrich; Dominik P. Modest; Marianne Sinn; Jana K. Striefler; Bernhard Opitz; Thorsten Goetze; Eike Gallmeier; Stefan Angermeier; Ludwig Fischer von Weikersthal; Lutz Jacobasch et al.
Source: check_circle
Crossref

Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy

International Journal of Cancer
2024-06-15 | Journal article
Contributors: Michael Masetti; Salah‐Eddin Al‐Batran; Thorsten O. Goetze; Peter Thuss‐Patience; Jorge Riera Knorrenschild; Eray Goekkurt; Gunnar Folprecht; Thomas Jens Ettrich; Udo Lindig; Kim Barbara Luley et al.
Source: check_circle
Crossref

Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors

Diagnostics
2024-01-16 | Journal article
Contributors: Daniel Vogele; Teresa Mueller; Daniel Wolf; Stephanie Otto; Sabitha Manoj; Michael Goetz; Thomas J. Ettrich; Meinrad Beer
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Neoadjuvante Therapie des Pankreaskarzinoms – neue Chancen

TumorDiagnostik & Therapie
2023-10 | Journal article
Contributors: Angelika Kestler; Thomas J. Ettrich
Source: check_circle
Crossref

Kommentar zu: KRAS-G12C-Hemmung: potenzielle Option auch beim Pankreaskarzinom?

Gastroenterologie up2date
2023-09 | Journal article
Contributors: Thomas J. Ettrich
Source: check_circle
Crossref

Gastroenteropancreatic Neuroendocrine Tumors—Current Status and Advances in Diagnostic Imaging

Diagnostics
2023-08-23 | Journal article
Contributors: Daniel Vogele; Stefan A. Schmidt; Daniel Gnutzmann; Wolfgang M. Thaiss; Thomas J. Ettrich; Marko Kornmann; Meinrad Beer; Markus S. Juchems
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Integrated Analysis of the RASH Study with the Use of the “Burden of Therapy” (BOTh<sup>®TM</sup>) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer

Current Oncology
2023-06 | Journal article | Author
Contributors: Klara Dorman; Stefan Boeck; Robert J. Snijder; Jens Siveke; Michael Schenk; Julia Mayerle; Karel Caca; Jens Freiberg-Richter; Ludwig Fischer von Weikersthal; Frank Kullmann et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Blood-Based Targeted Metabolomics Discriminate Patients with Alcoholic Liver Cirrhosis from Those with Non-Cirrhotic Liver Damage: An Explorative Study

Digestive Diseases
2022 | Journal article
Contributors: Jakob Johannes Meyer; Jens Dreyhaupt; Daniel Schwerdel; Thomas Jens Ettrich; Johanna Backhus; Matthias Maximilian Dollinger; Thomas Seufferlein; Andreas Wolfgang Berger
Source: check_circle
Crossref

Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling

Visceral Medicine
2022 | Journal article
Contributors: Thomas J. Ettrich; Niklas Sturm; Melanie Güthle; Felix J. Hüttner; Lukas Perkhofer
Source: check_circle
Crossref

Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

Cancers
2022-12-02 | Journal article
Contributors: Friedrich Sinner; Matthias Pinter; Bernhard Scheiner; Thomas Jens Ettrich; Niklas Sturm; Maria A. Gonzalez-Carmona; Oliver Waidmann; Fabian Finkelmeier; Vera Himmelsbach; Enrico N. De Toni et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL

Zeitschrift für Gastroenterologie
2022-11 | Journal article
Contributors: Thomas Seufferlein; Julia Mayerle; Stefan Böck; Thomas Brunner; Thomas J. Ettrich; Lars Grenacher; Thomas Mathias Gress; Thilo Hackert; Volker Heinemann; Angelika Kestler et al.
Source: check_circle
Crossref

Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions

Cancers
2022-11-14 | Journal article
Contributors: Niklas Sturm; Jasmin Selina Schuhbaur; Felix Hüttner; Lukas Perkhofer; Thomas Jens Ettrich
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

Journal of Clinical Oncology
2022-11-10 | Journal article
Contributors: Ralf-Dieter Hofheinz; Kirsten Merx; Georg M. Haag; Christoph Springfeld; Thomas Ettrich; Kersten Borchert; Albrecht Kretzschmar; Christian Teschendorf; Gabriele Siegler; Matthias P. Ebert et al.
Source: check_circle
Crossref

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX) - a randomized phase II trial of the AIO pancreatic cancer group

Annals of Oncology
2022-10 | Journal article
Part of ISSN: 0923-7534
Contributors: Thomas J. Ettrich
Source: Self-asserted source
Thomas J. Ettrich

Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial

American Journal of Gastroenterology
2022-06 | Journal article
Contributors: Thomas Seufferlein; Thomas J. Ettrich; Stefan Menzler; Helmut Messmann; Gerhard Kleber; Alexander Zipprich; Stefanie Frank-Gleich; Hana Algül; Klaus Metter; Frank Odemar et al.
Source: check_circle
Crossref

S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL

Zeitschrift für Gastroenterologie
2022-06 | Journal article
Contributors: Thomas Seufferlein; Julia Mayerle; Stefan Böck; Thomas Brunner; Thomas J. Ettrich; Lars Grenacher; Thomas Mathias Gress; Thilo Hackert; Volker Heinemann; Angelika Kestler et al.
Source: check_circle
Crossref

FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel – results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO

European Journal of Cancer
2022-04 | Journal article
Contributors: Sylvie Lorenzen; Peter Thuss-Patience; Claudia Pauligk; Eray Gökkurt; Thomas Ettrich; Florian Lordick; Michael Stahl; Peter Reichardt; Martin Sökler; Daniel Pink et al.
Source: check_circle
Crossref

Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients

Cancers
2022-02-21 | Journal article
Contributors: Mareike Waldenmaier; Lucas Schulte; Jonathan Schönfelder; Axel Fürstberger; Johann M. Kraus; Nora Daiss; Tanja Seibold; Mareen Morawe; Thomas J. Ettrich; Hans A. Kestler et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy

Cancers
2022-01-03 | Journal article
Contributors: Niklas Sturm; Thomas J. Ettrich; Lukas Perkhofer
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Computed Tomography-Based Tumor Heterogeneity Analysis Reveals Differences in a Cohort with Advanced Pancreatic Carcinoma under Palliative Chemotherapy

Visceral Medicine
2021 | Journal article
Contributors: Jochen Paul Steinacker; Nora Steinacker-Stanescu; Thomas Ettrich; Marko Kornmann; Katharina Kneer; Ambros Beer; Meinrad Beer; Stefan Andreas Schmidt
Source: check_circle
Crossref

Systemic Therapy for Metastatic Pancreatic Cancer

Current Treatment Options in Oncology
2021-11 | Journal article
Contributors: Thomas J. Ettrich; Thomas Seufferlein
Source: check_circle
Crossref

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

The Lancet Oncology
2021-10 | Journal article
Part of ISSN: 1470-2045
Source: Self-asserted source
Thomas J. Ettrich

A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response

Cancers
2021-05 | Journal article | Author
Contributors: Alica K. Beutel; Lena Schütte; Jeanette Scheible; Elodie Roger; Martin Müller; Lukas; Annika M. T. U. Kestler; Johann M. Kraus; Hans A. Kestler; Thomas F. E. Barth et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Nintedanib plus mFOLFOX6 as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phase II TRICC‐C study (AIO‐KRK‐0111)

International Journal of Cancer
2021-03-15 | Journal article
Contributors: Thomas J. Ettrich; Lukas Perkhofer; Thomas Decker; Ralf‐Dieter Hofheinz; Volker Heinemann; Thomas Hoffmann; Holger F. Hebart; Thomas Herrmann; Carla V. Hannig; Petra Büchner‐Steudel et al.
Source: check_circle
Crossref

Immunotherapy in Gastrointestinal Cancers

Visceral Medicine
2020 | Journal article
Contributors: Melanie Güthle; Thomas Ettrich; Thomas Seufferlein
Source: check_circle
Crossref

Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial

Trials
2020-07-10 | Journal article
Part of ISSN: 1745-6215
Source: Self-asserted source
Thomas J. Ettrich

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).

BMC cancer
2020-06-01 | Journal article
Source: Self-asserted source
Thomas J. Ettrich

Immunotherapy: Pancreatic Cancer and Extrahepatic Biliary Tract Cancer

Visceral Medicine
2019 | Journal article
Contributors: Lukas Perkhofer; Alica K. Beutel; Thomas J. Ettrich
Source: check_circle
Crossref

Molecular Approaches to Metastatic Colorectal Cancer: Better Diagnosis – Better Treatment?

Visceral Medicine
2019 | Journal article
Contributors: Thomas Seufferlein; Carolina Simões; Fernando Kude; Thomas J. Ettrich
Source: check_circle
Crossref

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

BMC Cancer
2018-12 | Journal article
Contributors: Thomas J. Ettrich; Andreas W. Berger; Lukas Perkhofer; Severin Daum; Alexander König; Andreas Dickhut; Uwe Wittel; Kai Wille; Michael Geissler; Hana Algül et al.
Source: check_circle
Crossref

Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'.

European journal of cancer (Oxford, England : 1990)
2018-05 | Journal article
Contributors: Haas M; Siveke JT; Schenk M; Lerch MM; Caca K; Freiberg-Richter J; Fischer von Weikersthal L; Kullmann F; Reinacher-Schick A; Fuchs M et al.
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017].

Zeitschrift fur Gastroenterologie
2018-04 | Journal article
Contributors: Ettrich TJ; Ebert M; Lorenzen S; Moehler M; Vogel A; Witkowski L; Seufferlein T; Reinacher-Schick A
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

EVITA-a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.

Annals of oncology : official journal of the European Society for Medical Oncology
2018-04 | Journal article
Contributors: Hofheinz RD; Lorenzen S; Trojan J; Ocvirk J; Ettrich TJ; Al-Batran SE; Schulz H; Homann N; Feustel HP; Schatz M et al.
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Advantages of a multi-state approach in surgical research: how intermediate events and risk factor profile affect the prognosis of a patient with locally advanced rectal cancer.

BMC medical research methodology
2018-02 | Journal article
Contributors: Manzini G; Ettrich TJ; Kremer M; Kornmann M; Henne-Bruns D; Eikema DA; Schlattmann P; de Wreede LC
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer.

Oncotarget
2018-01 | Journal article
Contributors: Berger AW; Schwerdel D; Ettrich TJ; Hann A; Schmidt SA; Kleger A; Marienfeld R; Seufferlein T
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.

2017 | Journal article
Contributors: Berger AW; Schwerdel D; Welz H; Marienfeld R; Schmidt SA; Kleger A; Ettrich TJ; Seufferlein T
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Surveillance after resection of pancreatic ductal adenocarcinoma with curative intent - a multicenter survey in Germany and review of the literature.

Zeitschrift fur Gastroenterologie
2017-07 | Journal article
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.

2016 | Journal article
Contributors: Ettrich TJ; Perkhofer L; von Wichert G; Gress TM; Michl P; Hebart HF; Büchner-Steudel P; Geissler M; Muche R; Danner B et al.
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Metastasiertes kolorektales Karzinom

Onkologe
2016-01 | Journal article
Contributors: T.J. Ettrich; T. Seufferlein
Source: Self-asserted source
Thomas J. Ettrich via Crossref Metadata Search

Therapie des metastasierten Pankreaskarzinoms

Onkologe
2015-10 | Journal article
Contributors: T.J. Ettrich; H. Oettle; T. Seufferlein
Source: Self-asserted source
Thomas J. Ettrich via Crossref Metadata Search

[Personalized tumor therapy for gastrointestinal tumors].

2015-09 | Journal article
Contributors: Ettrich TJ; Perkhofer L; Seufferlein T
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

[Colon Polypectomy - And Then?].

2015-08 | Journal article
Contributors: Berger AW; Ettrich TJ; Dollinger MM
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.

2015-07 | Journal article
Contributors: Zhu AX; Park JO; Ryoo BY; Yen CJ; Poon R; Pastorelli D; Blanc JF; Chung HC; Baron AD; Pfiffer TE et al.
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

[Therapy in pancreatic cancer - and still it moves along!].

2015-04 | Journal article
Contributors: Ettrich TJ; Perkhofer L; Seufferlein T
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Regorafenib.

2014 | Journal article
Contributors: Ettrich TJ; Seufferlein T
Source: Self-asserted source
Thomas J. Ettrich via Europe PubMed Central

Liver Metastases of Neuroendocrine Tumors and CCC

Locoregional Tumor Therapy
2014-08 | Other
Contributors: Thomas Ettrich; Thomas Seufferlein
Source: Self-asserted source
Thomas J. Ettrich via Crossref Metadata Search
Items per page:
Page 1 of 2